Perceptive Xontogeny Ventures logo

Perceptive Xontogeny Ventures

xontogeny.com

VCMatch tracks Perceptive Xontogeny Ventures as an investor focused on Biotech, Medtech, and Healthtech companies and Seed and Series A rounds. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Seed, Series A

Focus Areas

Biotech, Medtech, Healthtech

Geography

Not specified

Investment Thesis

Xontogeny operates as a hands-on life sciences accelerator that partners with entrepreneurs, scientific founders and first-time CEOs to advance technologies from early development to clinical proof-of-concept. The firm combines seed capital with an experienced internal team, deep networks of industry consultants and service providers, and active operational, strategic and investment leadership to shepherd programs across modalities (therapeutics, diagnostics, devices) toward compelling clinical validation and downstream financing or commercialization.

Is Perceptive Xontogeny Ventures right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

Investment Focus

Who should take a closer look

Perceptive Xontogeny Ventures is most relevant for founders raising Seed and Series A rounds in Biotech, Medtech, and Healthtech.

Focus statement

Focused exclusively on early-stage life sciences, Xontogeny invests across therapeutics, diagnostics and devices with the explicit objective of advancing programs to clinical proof-of-concept and supporting Series A venture activity (via the Perceptive Xontogeny Ventures Fund).

Value Add

  • Accelerator model with active collaboration — not a purely financial investor: "We are a life sciences accelerator that collaborates with entrepreneurs, scientific founders and first-time CEOs".
  • Combination of seed capital plus operational, strategic and board-level support to drive programs to clinical proof-of-concept: "seed investment capital ... with the singular goal of shepherding each program through a compelling clinical proof-of-concept study."
  • Deep network of industry consultants and service providers to execute development plans.
  • Team-level breadth across scientific diligence, drug and medical technology development and operations from preclinical through commercialization: "Xontogeny’s team has experience across scientific diligence, drug and medical technology development and operations from preclinical stages through commercialization."
  • Close linkage to Perceptive Advisors and a venture fund vehicle (Perceptive Xontogeny Ventures Fund) to support follow-on Series A investments across biotech, medtech and healthtech.

Stage And Sector Fit

Portfolio Highlights

Neurosterix

Biotech

Solid Biosciences

Biotech

Renovia

Medtech

Terns Pharmaceuticals

Biotech

UnLearn AI

Ai Ml

Yleana Leadership Foundation

Nonprofit

Sarepta Therapeutics

Biotech

Celgene

Biotech

+ 8 more companies in their portfolio